English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Lincoln Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Lincoln Pharmaceuticals

    Small Cap
    ₹612.9
    +2.35 (0.38%)
    01 July, 2024 06:40 BSE: 531633 NSE: LINCOLNISIN: INE405C01035

    Start SIP in Lincoln Pharmaceuticals

    Start SIP

    Lincoln Pharmaceuticals Performance

    Day Range

    • Low 610
    • High 620
    ₹ 612

    52 Week Range

    • Low 392
    • High 755
    ₹ 612
    • Open Price615
    • Previous Close611
    • Volume22760

    Lincoln Pharmaceuticals Share Price

    • Over 1 Month +7.41%
    • Over 3 Month +4.58%
    • Over 6 Month +0.56%
    • Over 1 Year +51.15%

    Lincoln Pharmaceuticals Key Statistics

    P/E Ratio 13.2
    PEG Ratio 0.5
    Market Cap Cr 1,228
    Price to Book Ratio 2.1
    EPS 46.6
    Dividend 0.2
    Relative Strength Index 57.36
    Money Flow Index 62.76
    MACD Signal 7.73
    Average True Range 17.87
    Lincoln Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 142146156136112
    Operating Expenses Qtr Cr 12411712511596
    Operating Profit Qtr Cr 1830312117
    Depreciation Qtr Cr 33332
    Interest Qtr Cr 00001
    Tax Qtr Cr 410964
    Net Profit Qtr Cr 1928281913
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 615533
    Operating Expenses Annual Cr 481421
    Operating Profit Annual in Cr 10089
    Depreciation Cr 119
    Interest Annual Cr 12
    Tax Annual Cr 2928
    Net Profit Annual Cr 9373
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 6339
    Cash from Investing Activity Annual Cr -57-37
    Cash from Financing Annual Activity Cr -5-5
    Net Cash Flow Annual Cr -2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 593502
    Fixed Assets Annual Cr 183157
    Total Non Current Assets Annual Cr 254220
    Total Current Assets Annual Cr 447367
    Total Assets Annual Cr 700587
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 296251
    ROE Annual % 1615
    ROCE Annual % 2020
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2322
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 142146156136112
    Operating Expenses Qtr Cr 12411712511596
    Operating Profit Qtr Cr 1830312117
    Depreciation Qtr Cr 33332
    Interest Qtr Cr 00001
    Tax Qtr Cr 410964
    Net Profit Qtr Cr 1928281913
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 615533
    Operating Expenses Annual Cr 481421
    Operating Profit Annual in Cr 10089
    Depreciation Cr 119
    Interest Annual Cr 12
    Tax Annual Cr 2928
    Net Profit Annual Cr 9373
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 6339
    Cash from Investing Activity Annual Cr -57-37
    Cash from Financing Annual Activity Cr -5-5
    Net Cash Flow Annual Cr -2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 593502
    Fixed Assets Annual Cr 183157
    Total Non Current Assets Annual Cr 254220
    Total Current Assets Annual Cr 447367
    Total Assets Annual Cr 700587
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 296251
    ROE Annual % 1615
    ROCE Annual % 2020
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2322
    Invest in Lincoln Pharmaceuticals

    Lincoln Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹612.9
    +2.35 (0.38%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹603.15
    • 50 Day
    • ₹598.04
    • 100 Day
    • ₹599.73
    • 200 Day
    • ₹576.29
    • 20 Day
    • ₹600.16
    • 50 Day
    • ₹588.89
    • 100 Day
    • ₹611.67
    • 200 Day
    • ₹599.66

    Lincoln Pharmaceuticals Resistance and Support

    PIVOT
    ₹614.3
    Resistance
    First Resistance 618.60
    Second Resistance 624.30
    Third Resistance 628.60
    RSI 57.36
    MFI 62.76
    MACD Single Line 7.73
    MACD 8.20
    Support
    First Support 608.60
    Second Support 604.30
    Third Supoort 598.60

    Lincoln Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 24,636 1,430,366 58.06
    Week 31,292 1,803,057 57.62
    1 Month 51,135 3,099,269 60.61
    6 Month 91,779 4,260,363 46.42

    Lincoln Pharmaceuticals Result Highlights

    Lincoln Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.
    Market Cap 1,228
    Sales 581
    Shares in Float 1.00
    No of funds 34
    Yield 0.26
    Book Value 2.07
    U/D Vol ratio 0.8
    LTDebt / Equity
    Alpha 0.03
    Beta 0.97

    Lincoln Pharmaceuticals Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 49.53%49.8%50.53%48.67%
    Mutual Funds
    Foreign Portfolio Investors 3.93%3.22%2.59%1.74%
    Individual Investors 37.36%37.78%37.47%37.32%
    Others 9.18%9.2%9.41%12.27%

    Lincoln Pharmaceuticals Management

    Name Designation
    Mr. Kishor M Shah Chairman
    Mr. Mahendra G Patel Managing Director
    Mr. Hashmukh I Patel Whole Time Director
    Mr. Munjal M Patel Whole Time Director
    Mr. Ashish R Patel Whole Time Director
    Mr. Rajnikant G Patel Non Executive Director
    Mr. Meha M Patel Independent Director
    Mr. Saurin J Parikh Independent Director
    Mr. Pirabhai R Suthar Independent Director

    Lincoln Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Lincoln Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-16 Audited Results & Final Dividend
    2024-02-08 Quarterly Results
    2023-11-02 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-25 Audited Results & Dividend

    Lincoln Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Lincoln Pharmaceuticals FAQs

    What is Share Price of Lincoln Pharmaceuticals ?

    Lincoln Pharmaceuticals share price is ₹612 As on 01 July, 2024 | 06:26

    What is the Market Cap of Lincoln Pharmaceuticals ?

    The Market Cap of Lincoln Pharmaceuticals is ₹1227.6 Cr As on 01 July, 2024 | 06:26

    What is the P/E ratio of Lincoln Pharmaceuticals ?

    The P/E ratio of Lincoln Pharmaceuticals is 13.2 As on 01 July, 2024 | 06:26

    What is the PB ratio of Lincoln Pharmaceuticals ?

    The PB ratio of Lincoln Pharmaceuticals is 2.1 As on 01 July, 2024 | 06:26

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.